-
Hype or Helpful: Does Patient Involvement Strengthen Lung Cancer Research? Scientists Weigh In.
Read time: 1 minute. Patient research advocates bring their personal experience into the research process, helping studies ask questions that matter to people affected by lung -
How Can Mission-Driven Nonprofits and NGOs Impact Cancer Care at the Policy Level?
Read time: 1 minute. National Cancer Control Plans are meant to guide cancer prevention, diagnosis, treatment, and survivorship priorities for a country. But too often, lung cancer -
Do Primary Care Providers Have the Information They Need To Help Patients Get Screened for Lung Cancer?
Read time: 1 minute. Primary care providers (PCPs) are often the first trusted point of contact for people who may be eligible for lung cancer screening. New research from -
Where Do People Draw the Line When Balancing Treatment Benefits and Side Effects for Early-Stage Disease?
Read time: 1 minutes. For people with early-stage non-small cell lung cancer, expanding treatment options are welcome news—but they can also make decisions more complicated. Some -
What Is the Impact of Low-Grade Side Effects (Such As Diarrhea) on Patients’ Quality-of-Life?
Read time: 1 minute. When people hear the phrase “low grade” in cancer treatment, it can sound reassuring. But for patients, a side effect that is not life-threatening can still -
Testing an Innovative Approach To Promote Lung Cancer Screening in a Large Hospital System Serving Minority Populations
Read time: 1 minute. Getting screened for lung cancer can save lives, but many people who qualify for screening never receive it. A LUNGevity-supported study presented at the 2026